Thyrotrophin levels and coronary artery calcification: Cross-sectional results of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Carregando...
Imagem de Miniatura
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2017
Editora
WILEY
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CLINICAL ENDOCRINOLOGY, v.87, n.5, p.597-604, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: There is little information about the association between thyrotrophin (TSH) levels and coronary artery calcification (CAC). Our aim was to analyse the association between TSH quintiles and subclinical atherosclerosis measured by CAC, using baseline data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Design: Cross-sectional study. Patients: We excluded individuals using medications that affect thyroid function and who self-reported cardiovascular disease. We included euthyroid subjects and individuals with subclinical hypothyroidism (SCHypo) and subclinical hyperthyroidism (SCHyper). Logistic regression models evaluated CAC >100 Agatston units as the dependent variable, and increasing quintiles of TSH as the independent variable, adjusted for demographic and cardiovascular risk factors. Results: Our sample included 3836 subjects, mean age 49years (interquartile range 44-56); 1999 (52.1%) were female, 3551 (92.6%) were euthyroid, 239 (6.2%) had SCHypo and 46 (1.2%) had SCHyper. The frequency of women, White people and never smokers as well as body mass index and insulin resistance increased according to quintiles. The 1st quintile for TSH (0-0.99mIU/L) was associated with CAC >100, using the 3rd quintile (1.39-1.85mIU/L) as reference (adjusted OR=1.57, 95% CI: 1.05-2.35, P=.027), but no association was shown for the 5th quintile (2.68-35.5mIU/L) compared to the 3rd. Restricting the analysis to euthyroid subjects did not change the results. For women, but not for men, we observed a U-shaped curve with 1st and 5th TSH quintiles associated with CAC>100. Conclusion: Low and low-normal (1st quintile) TSH levels were associated with CAC>100Agatston units in a sample with subclinical thyroid disorders and euthyroid subjects.
Palavras-chave
cardiovascular disease, coronary artery calcification, subclinical atherosclerosis, subclinical hyperthyroidism, subclinical hypothyroidism, subclinical thyroid disease, thyroid disorders, thyrotrophin levels
Referências
  1. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  2. Barreto SM, 2016, J EPIDEMIOL COMMUN H, V70, P380, DOI 10.1136/jech-2015-205834
  3. Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780
  4. Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721
  5. Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043
  6. Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079
  7. Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033
  8. Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402
  9. Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6
  10. Delitala AP, 2015, NUTR METAB CARDIOVAS, V25, P1104, DOI 10.1016/j.numecd.2015.09.001
  11. Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100
  12. Fedeli LG, 2013, REV SAUDE PUBL, V47, P63, DOI 10.1590/S0034-8910.2013047003807
  13. Iervasi G, 2007, ARCH INTERN MED, V167, P1526, DOI 10.1001/archinte.167.14.1526
  14. Jabbar A, 2017, NAT REV CARDIOL, V14, P39, DOI 10.1038/nrcardio.2016.174
  15. Kim ES, 2012, THYROID, V22, P870, DOI 10.1089/thy.2011.0366
  16. Park HJ, 2016, CLIN ENDOCRINOL, V84, P889, DOI 10.1111/cen.12946
  17. Park YJ, 2011, EUR J ENDOCRINOL, V165, P115, DOI 10.1530/EJE-11-0014
  18. Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6
  19. de Miranda EJFP, 2016, NUTR METAB CARDIOVAS, V26, P915, DOI 10.1016/j.numecd.2016.06.005
  20. Posadas-Romero C, 2014, EUR J ENDOCRINOL, V171, P319, DOI 10.1530/EJE-14-0150
  21. Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460
  22. Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361
  23. Santos IS, 2017, ATHEROSCLEROSIS, V260, P34, DOI 10.1016/j.atherosclerosis.2017.03.011
  24. Santos IS, 2014, ATHEROSCLEROSIS, V237, P227, DOI 10.1016/j.atherosclerosis.2014.09.004
  25. Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
  26. Sgarbi JA, 2010, EUR J ENDOCRINOL, V162, P569, DOI 10.1530/EJE-09-0845
  27. Silva N, 2014, EUR J ENDOCRINOL, V171, P327, DOI 10.1530/EJE-14-0031
  28. Singer P., 2005, WERNER INGBARS THYRO, P553
  29. Spence JD, 2015, ARTERIOSCL THROM VAS, V35, P1910, DOI 10.1161/ATVBAHA.115.306209
  30. Volzke H, 2004, J CLIN ENDOCR METAB, V89, P2145, DOI 10.1210/jc.2003-031028
  31. Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467
  32. Zhang YY, 2014, ARTERIOSCL THROM VAS, V34, P2128, DOI 10.1161/ATVBAHA.114.303889
  33. Zhu LJ, 2014, CORONARY ARTERY DIS, V25, P427, DOI 10.1097/MCA.0000000000000095